Aspire Biopharma Faces Delisting Notice
Ticker: ASBPW · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1847345
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Aspire Biopharma (ASBP) got a delisting warning.
AI Summary
Aspire Biopharma Holdings, Inc. filed an 8-K on April 18, 2025, to report its notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp., with a name change date of February 22, 2021.
Why It Matters
This filing indicates potential issues with Aspire Biopharma's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Registrant
- PowerUp Acquisition Corp. (company) — Former Company Name
- PowsedrUp Acquisition Corp. (company) — Former Company Name
- April 18, 2025 (date) — Date of Report
- February 22, 2021 (date) — Date of Name Change
FAQ
What specific listing rule or standard has Aspire Biopharma Holdings, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Aspire Biopharma Holdings, Inc. has failed to satisfy, only that a notice has been issued.
What is the ticker symbol for Aspire Biopharma Holdings, Inc.?
The ticker symbol is not explicitly stated in this excerpt, but the former names suggest it might be related to an acquisition company.
When was the company formerly known as PowerUp Acquisition Corp.?
The company was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp. with a date of name change on February 22, 2021.
What is the business address of Aspire Biopharma Holdings, Inc.?
The business address is 194 Candelaro Drive, #233, Humacao, PR 00791.
What is the Standard Industrial Classification (SIC) code for Aspire Biopharma Holdings, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Aspire Biopharma Holdings, Inc. (ASBPW).